| Trial ID: | L1378 |
| Source ID: | NCT06807905
|
| Associated Drug: |
Heparin Anticoagulation
|
| Title: |
Efficiency and Biocompatibility in Hemodiafiltration Procedure
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease on Dialysis|Biocompatibility|Anticoagulation|Hemodiafiltration
|
| Interventions: |
DRUG: Heparin anticoagulation|DRUG: Citrate anticoagulation
|
| Outcome Measures: |
Primary: removal of small and medium molecules, The removal of small and medium molecules is different comparing citrate and heparin anticoagulation., during 4 hour dialysis | Secondary: biocompatibility, The biocompatibility of the procedure is different comparing citrate than with heparin anticoagulation., during 4 hour dialysis
|
| Sponsor/Collaborators: |
Sponsor: University Medical Centre Ljubljana
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2019-02-01
|
| Completion Date: |
2021-02-01
|
| Results First Posted: |
|
| Last Update Posted: |
2025-02-04
|
| Locations: |
University Medical Centre Ljubljana, Ljubljana, Slovenia, Ljubljana, 1000, Slovenia
|
| URL: |
https://clinicaltrials.gov/show/NCT06807905
|
